|Bid||0.00 x 1200|
|Ask||0.00 x 800|
|Day's Range||29.64 - 30.90|
|52 Week Range||24.33 - 45.85|
|Beta (5Y Monthly)||0.97|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||54.00|
Subscribe to Yahoo Finance Plus to view Fair Value for SRDX
Surmodics, Inc. ( NASDAQ:SRDX ) has not performed well recently and CEO Gary Maharaj will probably need to up their...
Haemonetics (HAE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EDEN PRAIRIE, Minn., January 31, 2023--Surmodics will hold its Annual Meeting of Shareholders on Thursday, February 9, at 4 p.m. CT, as a virtual meeting.